Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Click here to be automatically notified when we publish a stock exchange announcement.
Key information
2020 Third quarter results announcement
We will announce our third quarter 2020 results at 12:00 GMT, 08:00 EDT on Wednesday 28 October.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, Iain Mackay, CFO, and Luke Miels, President, Global Pharmaceuticals, at 14:00 GMT, 10:00 EDT.
Latest information
Press releases for media
- Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine
- ViiV Healthcare presents continued positive findings from first-ever implementation science study on integrating an investigational once-monthly injectable HIV treatment into US healthcare practices
- ViiV Healthcare presents positive new findings from two studies of its investigational, long-acting regimen of cabotegravir and rilpivirine, including five-year data showing long-term durability, efficacy, safety, and tolerability
- ViiV Healthcare announces analysis showing no antiretroviral therapy interruptions due to COVID-19 across its clinical development programme for investigational, long-acting cabotegravir and rilpivirine
Annual Report 2019
We published our Annual Report 2019 on 04 March 2020. View the summary and download the full report or individual sections.